Preclinical evaluation of prototype products

Yonsei Medical Journal

Volumn 40, Issue 6, 1999, Pages 530-535

  Park, Jong Chul ^a   Lee, Dong Hee ^a   Suh, Hwal ^a  

^a Yonsei University   (South Korea)

Author keywords

Biocompatibility; Biomaterial; Medical device; Preclinical evaluation; Safety

Indexed keywords

PYROGEN;

ANIMAL; APPARATUS, EQUIPMENT AND SUPPLIES; ARTICLE; CARCINOGEN TESTING; HEMOLYSIS; HUMAN; INSTRUMENT STERILIZATION;

ANIMALS; CARCINOGENICITY TESTS; EQUIPMENT AND SUPPLIES; HEMOLYSIS; HUMANS; PYROGENS; STERILIZATION;

EID: 0033249997     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1999.40.6.530     Document Type: Review

References (25)

1. ASTM F619. Standard practice for extraction of medical plastics. 1991.
2. U.S. Pharmacopeia. Pyrogen test. In: United States Pharmacopeial Convention, editors. United States Pharmacopeia. 22nd ed. Rockville (MD): Mack Publishing; 1990. p.1515.
3. Cooper JF. Principles and applications of the limulus test for pyrogen in parenteral drugs. Bull Parenter Drug Assoc 1975;3:122-30.
4. Weary M, Baker B. Utilization of the limulus amebocyte lysate test for pyrogen testing of large volume patenterals, administration sets and medical devices. Bull Parenter Drug Assoc 1977;31:1127-33.
5. ASTM F756. Standard practice for assessment of hemolytic properties of materials. 1993.
6. Shayne CG. Irritation and pyrogenicity. In: Safety evaluation of medical devices. New York: Marcel Dekker; 1997. p.97-116.
7. Autian J. Toxicological evaluation of biomaterials: Primary acute toxicity screening programme. Artif Organs 1977; 1:53-60.
8. Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test. Mutat Res 1975;31: 237-364.
9. Clive D, Spector JFS. Laboratory procedure for assessing specific locus mutations at the TK locus in cultures of L5178Y mouse lymphoma cells. Mutat Res 1975;31: 17-29.
10. Hsie AW, Couch DB, O'Neill JP. Utilization of a quantitative mammalian cell mutation system, CHO/HGPRT, in experimental mutagenesis and genetic Toxicology. In: Butterworth BE, editor. Strategies for Short-Term Testing for Mutagens/Carcinogens. 2nd ed. West Palm Beach Florida: CRC Press; 1979. p.39-54.
11. Heidelberger C, Freeman AE, Pienta RJ, Sivak A, Bertram JS, Casto BC, et al. Cell transformation by chemical agents - a review and analysis of the literature: A report of the U.S. Environmental protection agency gene-tox program. Mutat Res 1983;114:283-385.
12. Mitchell AD, Casciano DA, Meltz ML, Robinson DE, San RH, Williams GM, et al. Unscheduled DNA synthesis tests: A export of the U.S. environmental protection agency gene-tox program. Mutat Res 1983;123:363-410.
13. Anderson JM. Inflammatory response to implants. Trans Am Soc Artif Intern Organs 1988;34:101-7.
14. Bick PH. The immune system: organization and function. In: Dean JH, Luster MI, Munson AE, Amos H, editors. Immunotoxicology and Immunopharmacology. 2nd ed. New York: Raven Press; 1985. p.1-10.
15. Luster MI, Pait DG, Portier C, Rosenthal GJ, Germolec DR, Comment CE, et al. Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology. Toxicol Lett 1992;64-5 Spec No:71-8.
16. Budinski K. Engineering materials, properties and selection. 5th ed. Old Tappan (NJ): Prentice-Hall; 1995.
17. John VB. Introduction to engineering materials. 2nd ed. New York: MacMillan; 1983.
18. Levinson IJ. Statics and strength of materials. Englewood Cliffs (NJ): Prentice-Hall; 1971.
19. Kaminski EJ, Oglesby RJ, Wood NK, Sandrik J. The behavior of biological materials at different sites of implantation. J Biomed Mater Res 1968;2:81-8.
20. Leininger RI, Mirkovitch V, Peters A, Hawks WA. Change in properties of plastics during implantation. Trans Am Soc Artif Intern Organs 1964;10:320-2.
21. Pizzoferrato A, Ciapetti G, Savarino L, Stea S, Tarabusi C. Results of histological grading on 100 cases of hip prosthesis failure. Biomaterials 1988;9:314-8.
22. Turner JE, Lawrence WH, Autian J. Subacute toxicity testing of biomaterials using histopathologic evaluation of rabbit muscle tissue. J Biomed Mater Res 1973;7:39-58.
23. Ecanow B, Gold BH, Sadove M. The role of inert foreign bodies in the pathogenesis of cancer. Br J Cancer 1977; 36:397.
24. Farrar DB, Crump KS. Exact statistical tests for any carcinogenic effect in animal bioassays. Fundam Appl Toxicol 1988;11:652-63.
25. Hajian G. Statistical issues in the design and analysis of carcinogenicity bioassays. Toxicol Pathol 1983;11:83-9.